Technology Update: SCOUT Study for Tricuspid Regurgitation

The number of clinical trials in the heart valve industry is exploding. There are so many new technologies that are potentially transforming heart valve therapy as we know it. For example, in this video you can learn about the SCOUT feasibility study. The SCOUT study will evaluate the MItralign transcatheter device created to treat tricuspid regurgitation. Watch this video to learn about the goals of the SCOUT clinical trial from Dr. Charles Davidson at Northwestern Medicine. Dr. Davidson is a leading implanter of transcatheter heart valve devices. (Video posted on May 17, 2018)

Doctor Interviewed

Dr. Charles Davidson

Dr. Charles Davidson

Interventonal Cardiologist
Northwestern Medicine
Chicago, Illinois

(312) 926-8948

See My Profile